Giant Biogene Holding Co., Ltd is a leader in the bioactive ingredient-based professional skin treatment product industry in China. It designs, develops and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient.

The Group’s market share was approximately 1.1 % of China’s overall skin care and treatment market in terms of retail sales in 2021. It was the second-largest professional skin treatment product company in China in 2021. It is the first company to obtain a medical device registration for recombinant collagen-based product in China. Collgene (可麗金) and Comfy (可復美), its flagship brands of recombinant collagen-based products, were the third and the fourth best-selling professional skin treatment brands, respectively.

The Group’s product pipeline included 102 product candidates, comprising 49 functional skincare products, 37 medical dressings and four skin rejuvenation products under its beauty product portfolio, as well as two biomedical products, seven functional foods and three food products for special medical purposes under our health product portfolio.

The Group implements dual-pronged “medical institution mass consumer” sales strategy targeting both medical institutions and mass market. It had sold and distributed products to over 1,000 public hospitals, approximately 1,700 private hospitals and clinics, as well as approximately 300 pharmacy chain brands across China. In addition, it have also built a nationwide mass market sales network through direct sales and distributors.